Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize s... read more Featured Products: More products

Download Mobile App





PerkinElmer Demonstrates High-Throughput MSMS Dried Blood Spot Screening Solutions at Medlab Middle East 2021

By LabMedica International staff writers
Posted on 21 Jun 2021
PerkinElmer, Inc. More...
(Waltham, MA; USA) demonstrated its high-throughput MSMS dried blood spot screening solutions at the 2021 edition of Medlab Middle East, the leading medical laboratory exhibition in the region for over 20 years.

On display at the event was the PerkinElmer QSight 225 LC/MS/MS system developed uniquely for newborn screening with the option for tier 2 testing – using just a single heel-prick dried blood spot (DBS) card. The QSight system delivers a unique combination of self-cleaning MS/MS instrumentation that provides exceptional system uptime, a simple setup process, and easy-to-use database software that simplifies review and analysis - plus kits and reagents, training, and support. The QSight system includes a high capacity autosampler, precision binary pump, best in class MS detector, and easy to use instrument control and data analysis software that have been optimized to run hundreds of samples per day, for weeks at a time, to generate consistent results with minimum maintenance or downtime.

PerkinElmer also exhibited the Opera Phenix High Content Screening System, the premier confocal solution for today's most demanding high content applications. Drawing on over a decade of experience with the industry-leading Opera High Content Screening System, the Opera Phenix is designed for high-throughput, phenotypic screening and assays involving complex disease models, such as live cells, primary cells and microtissues. In addition, PerkinElmer highlighted the VICTOR Nivo multimode reader that breaks new ground, packing all popular detection modes into the industry’s smallest benchtop footprint. The successor to the highly popular VICTOR X system - the world’s first multimode plate reader - the VICTOR Nivo system detects absorbance, luminescence, fluorescence intensity, time-resolved fluorescence, fluorescence polarization and now Alpha technologies, making it perfect for everyday biochemical and cell-based assays, including kinetic measurements.

At this year’s Medlab Middle East, PerkinElmer displayed the LC 300 chromatography platform that redefines and simplifies LC, delivering the flexibility, performance, and efficiency to tackle challenging analytical demands. Users can choose between a 10k-psi system for HPLC and an 18k-psi system for ultraprecise UHPLC analysis. Both offer patented valve technology and sample handling options to accommodate multiple sample tray formats. And SimplicityChrom 21CFR11 software delivers intuitive instrument control, while an integrated color display shows immediate system status. Combined with CDS third-party drivers for commercial systems, this offers a powerful and simple LC solution. Also on display was the chemagic 360 instrument, with dimensions of only 80 x 80 cm and its unique sample volume flexibility, making it the ideal solution for nucleic acid isolation in human genetics, biobanking, HLA typing, viral and bacterial detection.

Related Links:
PerkinElmer, Inc.


New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Hematology System
Medonic M16C
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.